Toxicology Thesis Topics

This page covers FMT toxicology thesis topics across pesticide and agricultural poisoning, drug and pharmaceutical overdose, household, industrial and corrosive poisoning, alcohol and psychoactive substance toxicology, and clinical and forensic toxicology. The topics are intended for MD/MS Forensic Medicine and Toxicology candidates and are designed around poisoning patients, emergency and hospital records, occupational exposure groups, biological samples, toxicological reports and medicolegal autopsy material that can generally be studied within one thesis period. The list also supports candidates searching for forensic medicine toxicology research topics, while a structured FMT toxicology protocol or FMT toxicology synopsis can be developed once the exposure definition, sampling time, severity endpoint and toxicological confirmation method are fixed.

Last reviewed and updated: August 2026 · 2026–27 admissions

Pesticide and Agricultural Poisoning Thesis Topics

Organophosphates, carbamates, aluminium and zinc phosphides, paraquat and other herbicides, pyrethroids, rodenticides, occupational agrochemical exposure, and determinants of clinical severity. MD/MS Forensic Medicine and Toxicology dissertation titles aligned to NMC curriculum requirements.

  1. Clinical profile and factors associated with severity among patients with acute organophosphate poisoning presenting to a tertiary care hospital in India: a cross-sectional observational study.
  2. Association of serum cholinesterase levels with clinical severity of acute organophosphate poisoning: a hospital-based cross-sectional study.
  3. Relationship between serum cholinesterase levels and requirement for mechanical ventilation in acute organophosphate poisoning: a cross-sectional analytical study.
  4. Association between Peradeniya Organophosphorus Poisoning Scale at admission and severity of acute organophosphate poisoning: a cross-sectional observational study.
  5. Comparison of clinical and biochemical characteristics of patients with mild, moderate, and severe acute organophosphate poisoning: a hospital-based comparative cross-sectional study.
  6. Electrocardiographic abnormalities and their association with poisoning severity in patients with acute organophosphate poisoning: a cross-sectional observational study.
  7. Association of corrected QT interval prolongation with clinical severity in acute organophosphate poisoning: a hospital-based cross-sectional study.
  8. Serum electrolyte abnormalities and their association with clinical severity in acute organophosphate poisoning: a cross-sectional analytical study.
  9. Association of admission serum potassium levels with severity of acute organophosphate poisoning: a cross-sectional observational study.
  10. Association of admission serum sodium levels with neurological manifestations in acute organophosphate poisoning: a hospital-based cross-sectional study.
  11. Serum amylase levels and their association with clinical severity in patients with acute organophosphate poisoning: a cross-sectional analytical study.
  12. Serum lipase levels and their association with severity of acute organophosphate poisoning: a hospital-based observational study.
  13. Association of hyperglycaemia at admission with clinical severity in acute organophosphate poisoning: a cross-sectional study.
  14. Association between admission random blood glucose and requirement for ventilatory support in patients with acute organophosphate poisoning: a cross-sectional analytical study.
  15. Leucocyte count and neutrophil-to-lymphocyte ratio as markers of severity in acute organophosphate poisoning: a hospital-based cross-sectional study.
  16. Association of platelet-to-lymphocyte ratio with clinical severity in acute organophosphate poisoning: a cross-sectional observational study.
  17. Association between red cell distribution width and severity of acute organophosphate poisoning: a hospital-based cross-sectional study.
  18. Association of admission serum lactate with clinical severity in patients with acute organophosphate poisoning: a cross-sectional analytical study.
  19. Acid-base abnormalities and their association with clinical severity in acute organophosphate poisoning: a hospital-based observational study.
  20. Relationship between arterial blood gas parameters at presentation and severity of acute organophosphate poisoning: a cross-sectional study.
  21. Clinical spectrum of neurological manifestations in acute organophosphate poisoning and their association with poisoning severity: a cross-sectional observational study.
  22. Frequency and clinical correlates of acute cholinergic manifestations among patients with organophosphate poisoning: a hospital-based cross-sectional study.
  23. Association of pupillary size at presentation with severity of acute organophosphate poisoning: a cross-sectional analytical study.
  24. Respiratory manifestations and factors associated with requirement for invasive mechanical ventilation in acute organophosphate poisoning: a cross-sectional observational study.
  25. Association between Glasgow Coma Scale score at admission and clinical severity of acute organophosphate poisoning: a hospital-based cross-sectional study.
  26. Comparison of Peradeniya Organophosphorus Poisoning Scale and Glasgow Coma Scale for assessment of severity in acute organophosphate poisoning: a cross-sectional comparative study.
  27. Association of liver function abnormalities with clinical severity in patients with acute organophosphate poisoning: a cross-sectional analytical study.
  28. Renal function abnormalities and their association with clinical severity in acute organophosphate poisoning: a hospital-based observational study.
  29. Clinical and biochemical profile of acute organophosphate poisoning according to the type of organophosphate compound consumed: a comparative cross-sectional study.
  30. Association between estimated quantity of organophosphate ingestion and clinical severity at presentation: a hospital-based cross-sectional study.
  31. Clinical profile and severity determinants of acute carbamate poisoning in adults presenting to a tertiary care hospital: a cross-sectional observational study.
  32. Clinical and biochemical comparison of acute organophosphate and carbamate poisoning: a hospital-based comparative cross-sectional study.
  33. Comparison of cholinergic manifestations in patients with acute organophosphate and carbamate poisoning: a cross-sectional comparative study.
  34. Comparison of electrocardiographic abnormalities between acute organophosphate and carbamate poisoning: a hospital-based cross-sectional study.
  35. Comparison of serum cholinesterase levels and clinical severity between acute organophosphate and carbamate poisoning: a comparative cross-sectional study.
  36. Association of admission biochemical abnormalities with severity of acute carbamate poisoning: a cross-sectional observational study.
  37. Clinical profile and factors associated with severe poisoning among patients with aluminium phosphide ingestion: a hospital-based cross-sectional study.
  38. Electrocardiographic abnormalities in acute aluminium phosphide poisoning and their association with clinical severity: a cross-sectional observational study.
  39. Association of admission blood pressure with clinical severity in patients with acute aluminium phosphide poisoning: a hospital-based cross-sectional study.
  40. Association of metabolic acidosis at presentation with severity of acute aluminium phosphide poisoning: a cross-sectional analytical study.
  41. Association between serum lactate levels and clinical severity in acute aluminium phosphide poisoning: a hospital-based cross-sectional study.
  42. Serum electrolyte abnormalities and their relationship with severity of acute aluminium phosphide poisoning: a cross-sectional observational study.
  43. Association of admission serum magnesium levels with electrocardiographic abnormalities in acute aluminium phosphide poisoning: a cross-sectional analytical study.
  44. Association between blood glucose abnormalities and severity of acute aluminium phosphide poisoning: a hospital-based cross-sectional study.
  45. Hepatic and renal biochemical abnormalities in acute aluminium phosphide poisoning and their association with clinical severity: a cross-sectional observational study.
  46. Haematological abnormalities and their association with severity in patients with acute aluminium phosphide poisoning: a hospital-based cross-sectional study.
  47. Association of neutrophil-to-lymphocyte ratio with clinical severity in acute aluminium phosphide poisoning: a cross-sectional analytical study.
  48. Relationship between arterial blood gas parameters and haemodynamic instability in acute aluminium phosphide poisoning: a hospital-based cross-sectional study.
  49. Clinical and biochemical comparison of patients with aluminium phosphide poisoning with and without shock at presentation: a comparative cross-sectional study.
  50. Comparison of clinical severity parameters between aluminium phosphide and organophosphate poisoning: a hospital-based comparative study.
  51. Clinical profile and severity indicators in patients with acute paraquat poisoning presenting to a tertiary care hospital: a cross-sectional observational study.
  52. Association of admission renal function parameters with clinical severity in acute paraquat poisoning: a cross-sectional analytical study.
  53. Association of liver function abnormalities with severity of acute paraquat poisoning: a hospital-based cross-sectional study.
  54. Relationship between arterial blood gas abnormalities and clinical severity in acute paraquat poisoning: a cross-sectional observational study.
  55. Association of serum lactate with severity of acute paraquat poisoning: a hospital-based cross-sectional analytical study.
  56. Haematological abnormalities and their association with clinical severity in patients with acute paraquat poisoning: a cross-sectional study.
  57. Association of neutrophil-to-lymphocyte ratio with severity of acute paraquat poisoning: a hospital-based observational study.
  58. Clinical and biochemical comparison of patients with paraquat poisoning presenting early and those presenting late after ingestion: a comparative cross-sectional study.
  59. Association between estimated amount of paraquat ingestion and clinical severity at presentation: a hospital-based cross-sectional study.
  60. Comparison of renal and hepatic dysfunction at presentation between paraquat and other herbicide poisonings: a comparative cross-sectional study.
  61. Clinical manifestations and severity profile of acute pyrethroid poisoning in adults: a hospital-based cross-sectional observational study.
  62. Neurological manifestations and their association with severity of acute pyrethroid poisoning: a cross-sectional study.
  63. Respiratory manifestations and their association with clinical severity in patients with acute pyrethroid poisoning: a hospital-based cross-sectional study.
  64. Electrocardiographic abnormalities in acute pyrethroid poisoning and their association with clinical severity: a cross-sectional observational study.
  65. Biochemical abnormalities and their relationship with severity of acute pyrethroid poisoning: a hospital-based cross-sectional study.
  66. Comparison of clinical manifestations of acute pyrethroid and organophosphate poisoning: a comparative cross-sectional study.
  67. Comparison of neurological manifestations between acute pyrethroid and organophosphate poisoning: a hospital-based comparative study.
  68. Comparison of electrocardiographic abnormalities in acute pyrethroid and organophosphate poisoning: a cross-sectional comparative study.
  69. Clinical profile of acute herbicide poisoning presenting to a tertiary care hospital: a cross-sectional observational study.
  70. Clinical and biochemical characteristics of glyphosate-based herbicide poisoning and their association with severity: a hospital-based cross-sectional study.
  71. Association of gastrointestinal manifestations with clinical severity in acute herbicide poisoning: a cross-sectional analytical study.
  72. Renal and hepatic abnormalities in acute herbicide poisoning and their association with poisoning severity: a hospital-based observational study.
  73. Electrolyte and acid-base abnormalities among patients with acute herbicide poisoning: a cross-sectional study.
  74. Comparison of clinical and biochemical manifestations of paraquat and non-paraquat herbicide poisoning: a hospital-based comparative cross-sectional study.
  75. Clinical profile of acute rodenticide poisoning among adults presenting to a tertiary care hospital: a cross-sectional observational study.
  76. Clinical and biochemical characteristics of zinc phosphide poisoning and their association with severity: a hospital-based cross-sectional study.
  77. Electrocardiographic abnormalities and their association with clinical severity in acute zinc phosphide poisoning: a cross-sectional observational study.
  78. Association of metabolic acidosis with clinical severity in patients with acute zinc phosphide poisoning: a hospital-based cross-sectional study.
  79. Hepatic dysfunction and its association with clinical severity in acute rodenticide poisoning: a cross-sectional analytical study.
  80. Coagulation abnormalities among patients with anticoagulant rodenticide poisoning: a hospital-based cross-sectional observational study.
  81. Clinical manifestations and coagulation profile in patients with anticoagulant rodenticide poisoning: a cross-sectional study.
  82. Comparison of clinical and biochemical manifestations of aluminium phosphide and zinc phosphide poisoning: a hospital-based comparative cross-sectional study.
  83. Comparison of hepatic and renal dysfunction between phosphide and non-phosphide rodenticide poisoning: a cross-sectional comparative study.
  84. Pattern of pesticide poisoning and distribution of implicated compounds among patients presenting to a tertiary care hospital in an agricultural region of India: a cross-sectional observational study.
  85. Demographic and clinical profile of patients with acute agricultural pesticide poisoning presenting to the emergency department: a hospital-based cross-sectional study.
  86. Comparison of clinical severity of pesticide poisoning among agricultural workers and non-agricultural workers: a cross-sectional comparative study.
  87. Association of occupational pesticide exposure with cholinergic symptoms among agricultural workers: a community-based cross-sectional study.
  88. Serum cholinesterase levels and their association with occupational pesticide exposure among agricultural workers: a comparative cross-sectional study.
  89. Comparison of serum cholinesterase levels between pesticide applicators and agricultural workers not directly involved in pesticide application: a cross-sectional comparative study.
  90. Association between use of personal protective measures and self-reported acute pesticide-related symptoms among pesticide applicators: a community-based cross-sectional study.
  91. Knowledge, attitudes, and practices regarding safe pesticide handling among agricultural workers in rural India: a community-based cross-sectional study.
  92. Association of pesticide storage and handling practices with self-reported poisoning symptoms among farmers: a community-based analytical cross-sectional study.
  93. Knowledge and practices regarding first aid for pesticide poisoning among farmers and pesticide handlers: a community-based cross-sectional study.
  94. Comparison of knowledge and safety practices related to pesticide use between trained and untrained agricultural workers: a community-based comparative cross-sectional study.
  95. Pattern of personal protective equipment use and factors associated with inadequate protection among pesticide applicators: a community-based cross-sectional study.
  96. Association between duration and intensity of occupational pesticide exposure and neurological symptoms among agricultural workers: a cross-sectional analytical study.
  97. Comparison of respiratory symptoms and spirometric parameters between pesticide-exposed agricultural workers and non-exposed controls: a comparative cross-sectional study.
  98. Comparison of haematological and liver function parameters between pesticide-exposed agricultural workers and non-exposed controls: a cross-sectional comparative study.
  99. Pattern of intentional and accidental agrochemical poisoning and their clinical differences among patients presenting to a tertiary care emergency department: a comparative cross-sectional study.
  100. Comparative clinical and biochemical profile of major classes of acute agricultural poisoning including organophosphates, carbamates, phosphides, pyrethroids, herbicides, and rodenticides presenting to a tertiary care hospital: a hospital-based cross-sectional study.

Drug and Pharmaceutical Poisoning Thesis Topics

Paracetamol, sedative-hypnotics, antidepressants, antipsychotics, antiepileptics, cardiovascular medicines, opioid analgesics, and multi-medicine pharmaceutical poisoning presentations in emergency and forensic medicine settings.

  1. Clinical and biochemical profile of acute paracetamol poisoning among adults presenting to a tertiary care hospital in India: a cross-sectional observational study.
  2. Association between reported dose of paracetamol ingestion and hepatic biochemical abnormalities at presentation in acute paracetamol poisoning: a cross-sectional analytical study.
  3. Association of time interval between paracetamol ingestion and hospital presentation with clinical severity at initial assessment: a hospital-based cross-sectional study.
  4. Pattern of liver function abnormalities among patients presenting with acute paracetamol overdose: a cross-sectional observational study.
  5. Association of serum aminotransferase levels with clinical severity at presentation in acute paracetamol poisoning: a hospital-based cross-sectional study.
  6. Coagulation abnormalities and their association with hepatic dysfunction in acute paracetamol poisoning: a cross-sectional analytical study.
  7. Association of admission serum lactate with clinical severity in acute paracetamol poisoning: a hospital-based cross-sectional study.
  8. Acid-base and electrolyte abnormalities among patients with acute paracetamol poisoning: a cross-sectional observational study.
  9. Comparison of clinical and biochemical characteristics between isolated paracetamol poisoning and paracetamol-containing multidrug poisoning: a comparative cross-sectional study.
  10. Comparison of clinical severity at presentation between patients with therapeutic excess and intentional acute paracetamol overdose: a hospital-based comparative study.
  11. Clinical profile and severity indicators among patients with acute benzodiazepine poisoning presenting to a tertiary care hospital: a cross-sectional observational study.
  12. Association between Glasgow Coma Scale score and clinical severity in acute benzodiazepine poisoning: a hospital-based cross-sectional study.
  13. Clinical and biochemical characteristics of patients with isolated benzodiazepine overdose: a cross-sectional observational study.
  14. Association of reported benzodiazepine dose with level of consciousness at presentation: a cross-sectional analytical study.
  15. Electrocardiographic abnormalities among patients presenting with acute benzodiazepine poisoning: a hospital-based cross-sectional study.
  16. Respiratory abnormalities and factors associated with respiratory depression at presentation in acute benzodiazepine poisoning: a cross-sectional observational study.
  17. Comparison of clinical manifestations between isolated benzodiazepine poisoning and benzodiazepine poisoning with co-ingestants: a comparative cross-sectional study.
  18. Comparison of neurological manifestations among patients with poisoning due to different commonly used benzodiazepines: a hospital-based comparative cross-sectional study.
  19. Association of age and comorbidities with severity of acute benzodiazepine poisoning at presentation: a cross-sectional analytical study.
  20. Comparison of clinical severity between benzodiazepine and non-benzodiazepine sedative-hypnotic poisoning: a hospital-based comparative study.
  21. Clinical and electrocardiographic profile of acute tricyclic antidepressant poisoning: a cross-sectional observational study.
  22. Association of QRS complex duration with neurological severity in acute tricyclic antidepressant poisoning: a cross-sectional analytical study.
  23. Association of corrected QT interval prolongation with clinical severity in acute antidepressant poisoning: a hospital-based cross-sectional study.
  24. Electrocardiographic abnormalities and their relationship with clinical manifestations in acute antidepressant overdose: a cross-sectional observational study.
  25. Acid-base abnormalities and their association with electrocardiographic changes in acute tricyclic antidepressant poisoning: a hospital-based cross-sectional study.
  26. Association of Glasgow Coma Scale score with electrocardiographic abnormalities in acute tricyclic antidepressant poisoning: a cross-sectional analytical study.
  27. Clinical and biochemical profile of selective serotonin reuptake inhibitor overdose presenting to a tertiary care hospital: a cross-sectional observational study.
  28. Comparison of clinical manifestations between tricyclic antidepressant and selective serotonin reuptake inhibitor poisoning: a comparative cross-sectional study.
  29. Comparison of electrocardiographic abnormalities between tricyclic antidepressant and selective serotonin reuptake inhibitor overdose: a hospital-based comparative study.
  30. Pattern of neurological manifestations in acute antidepressant poisoning and their association with the class of antidepressant ingested: a cross-sectional study.
  31. Clinical and electrocardiographic profile of acute antipsychotic drug poisoning: a hospital-based cross-sectional observational study.
  32. Association of corrected QT interval prolongation with clinical severity in acute antipsychotic poisoning: a cross-sectional analytical study.
  33. Frequency and pattern of cardiac conduction abnormalities among patients with acute antipsychotic overdose: a hospital-based cross-sectional study.
  34. Neurological manifestations and their association with severity of acute antipsychotic poisoning: a cross-sectional observational study.
  35. Association of admission Glasgow Coma Scale score with clinical severity in acute antipsychotic drug overdose: a hospital-based cross-sectional study.
  36. Metabolic and electrolyte abnormalities among patients with acute antipsychotic poisoning: a cross-sectional observational study.
  37. Comparison of clinical manifestations between first-generation and second-generation antipsychotic drug poisoning: a comparative cross-sectional study.
  38. Comparison of electrocardiographic abnormalities between first-generation and second-generation antipsychotic drug overdose: a hospital-based comparative study.
  39. Clinical profile of acute olanzapine poisoning and factors associated with severe central nervous system depression: a cross-sectional study.
  40. Clinical and electrocardiographic profile of acute quetiapine poisoning presenting to a tertiary care hospital: a cross-sectional observational study.
  41. Clinical profile and severity indicators among patients with acute opioid poisoning: a hospital-based cross-sectional observational study.
  42. Association of Glasgow Coma Scale score with respiratory depression in acute opioid poisoning: a cross-sectional analytical study.
  43. Respiratory manifestations and their association with clinical severity in patients with acute opioid overdose: a hospital-based cross-sectional study.
  44. Association of pupillary findings with level of consciousness in acute opioid poisoning: a cross-sectional observational study.
  45. Acid-base and arterial blood gas abnormalities among patients presenting with acute opioid poisoning: a hospital-based cross-sectional study.
  46. Electrocardiographic abnormalities and their association with severity of acute opioid poisoning: a cross-sectional analytical study.
  47. Association of admission oxygen saturation with neurological severity in acute opioid poisoning: a hospital-based cross-sectional study.
  48. Comparison of clinical manifestations between isolated opioid poisoning and opioid poisoning with co-ingestants: a comparative cross-sectional study.
  49. Comparison of clinical and respiratory manifestations between prescription opioid overdose and other opioid poisoning: a hospital-based comparative study.
  50. Clinical characteristics of patients presenting with opioid toxidrome to a tertiary care emergency department: a cross-sectional observational study.
  51. Clinical and biochemical profile of acute antiepileptic drug poisoning: a hospital-based cross-sectional observational study.
  52. Neurological manifestations and their association with severity of acute antiepileptic drug poisoning: a cross-sectional analytical study.
  53. Electrocardiographic abnormalities among patients with acute antiepileptic drug overdose: a hospital-based cross-sectional study.
  54. Association of serum sodium abnormalities with neurological manifestations in acute antiepileptic drug poisoning: a cross-sectional observational study.
  55. Clinical and biochemical profile of acute valproate poisoning and its association with severity: a hospital-based cross-sectional study.
  56. Association of serum ammonia levels with neurological manifestations in acute valproate poisoning: a cross-sectional analytical study.
  57. Clinical and electrocardiographic profile of acute carbamazepine poisoning: a hospital-based cross-sectional observational study.
  58. Association of serum sodium levels with clinical severity in acute carbamazepine poisoning: a cross-sectional study.
  59. Comparison of clinical and biochemical manifestations of valproate and carbamazepine poisoning: a comparative cross-sectional study.
  60. Comparison of neurological manifestations between older and newer generation antiepileptic drug poisoning: a hospital-based comparative study.
  61. Clinical and electrocardiographic profile of acute beta-adrenergic blocker poisoning: a cross-sectional observational study.
  62. Association of bradycardia and hypotension at presentation with clinical severity in acute beta-adrenergic blocker poisoning: a cross-sectional analytical study.
  63. Blood glucose abnormalities and their association with clinical severity in acute beta-adrenergic blocker poisoning: a hospital-based cross-sectional study.
  64. Clinical and electrocardiographic profile of acute calcium channel blocker poisoning: a cross-sectional observational study.
  65. Association of hyperglycaemia with haemodynamic severity in acute calcium channel blocker poisoning: a hospital-based cross-sectional study.
  66. Electrolyte and acid-base abnormalities in acute calcium channel blocker poisoning and their association with clinical severity: a cross-sectional analytical study.
  67. Comparison of haemodynamic and electrocardiographic manifestations between beta-adrenergic blocker and calcium channel blocker poisoning: a comparative cross-sectional study.
  68. Comparison of blood glucose abnormalities between beta-adrenergic blocker and calcium channel blocker poisoning: a hospital-based comparative study.
  69. Clinical profile of acute digoxin poisoning and association of electrocardiographic abnormalities with clinical severity: a cross-sectional observational study.
  70. Association of serum potassium abnormalities with electrocardiographic manifestations in acute digoxin poisoning: a hospital-based cross-sectional study.
  71. Clinical and electrocardiographic profile of acute antihypertensive medication overdose presenting to a tertiary care hospital: a cross-sectional observational study.
  72. Comparison of clinical severity among different classes of cardiovascular drug poisoning: a hospital-based comparative cross-sectional study.
  73. Pattern and clinical profile of multidrug poisoning among adults presenting to a tertiary care emergency department: a cross-sectional observational study.
  74. Comparison of clinical severity between single-drug and multidrug poisoning: a hospital-based comparative cross-sectional study.
  75. Comparison of neurological manifestations between single-drug and multidrug overdose: a cross-sectional comparative study.
  76. Comparison of electrocardiographic abnormalities between single-drug and multidrug poisoning: a hospital-based comparative study.
  77. Association between number of drugs ingested and clinical severity at presentation in multidrug poisoning: a cross-sectional analytical study.
  78. Association of sedative co-ingestion with level of consciousness among patients with multidrug poisoning: a hospital-based cross-sectional study.
  79. Pattern of drug combinations and associated toxidromes among patients with multidrug poisoning: a cross-sectional observational study.
  80. Clinical and biochemical characteristics of psychotropic multidrug overdose presenting to a tertiary care hospital: a hospital-based cross-sectional study.
  81. Pattern of acute pharmaceutical poisoning among adults presenting to a tertiary care emergency department in India: a cross-sectional observational study.
  82. Demographic, clinical, and toxicological profile of patients presenting with intentional medication overdose: a hospital-based cross-sectional study.
  83. Pattern of medications implicated in intentional pharmaceutical poisoning among adults presenting to a tertiary care hospital: a cross-sectional observational study.
  84. Comparison of clinical characteristics of intentional and accidental pharmaceutical poisoning: a hospital-based comparative cross-sectional study.
  85. Comparison of patterns of pharmaceutical poisoning between younger and older adults presenting to the emergency department: a comparative cross-sectional study.
  86. Comparison of clinical severity of pharmaceutical poisoning between males and females: a hospital-based comparative study.
  87. Association between delay in hospital presentation and clinical severity among patients with acute medication overdose: a cross-sectional analytical study.
  88. Association of reported quantity of medication ingested with clinical severity at emergency department presentation: a hospital-based cross-sectional study.
  89. Association between reported quantity of medication ingested and level of consciousness in acute pharmaceutical poisoning: a cross-sectional analytical study.
  90. Clinical utility of Glasgow Coma Scale score for assessment of severity among patients with acute pharmaceutical poisoning: a hospital-based cross-sectional study.
  91. Electrocardiographic abnormalities and their association with clinical severity among patients with acute pharmaceutical poisoning: a cross-sectional observational study.
  92. Corrected QT interval prolongation and its association with implicated drug class in acute pharmaceutical poisoning: a hospital-based analytical cross-sectional study.
  93. Pattern of acid-base disturbances among patients with acute medication overdose and their association with clinical severity: a cross-sectional observational study.
  94. Electrolyte abnormalities and their association with neurological and cardiovascular manifestations in acute pharmaceutical poisoning: a hospital-based cross-sectional study.
  95. Association of admission blood glucose abnormalities with clinical severity among patients with acute medication overdose: a cross-sectional analytical study.
  96. Haematological and biochemical abnormalities among patients with acute pharmaceutical poisoning: a hospital-based observational study.
  97. Comparison of clinical and electrocardiographic manifestations between psychotropic and non-psychotropic medication overdose: a comparative cross-sectional study.
  98. Comparison of poisoning severity between prescription-only and over-the-counter medication overdose: a hospital-based comparative cross-sectional study.
  99. Pattern of medication sources and circumstances of exposure among patients with intentional pharmaceutical poisoning: a cross-sectional observational study.
  100. Spectrum of acute drug and pharmaceutical poisoning and factors associated with severe presentation among patients attending a tertiary care emergency department in India: a hospital-based analytical cross-sectional study.

Household, Industrial and Corrosive Poisoning Thesis Topics

Corrosive ingestion, hydrocarbons, household cleaning agents, organic solvents, toxic alcohols, carbon monoxide, and occupational chemical exposure among industrial workers.

  1. Clinical and endoscopic profile of acute corrosive ingestion among adults presenting to a tertiary care hospital in India: a cross-sectional observational study.
  2. Association between clinical manifestations at presentation and severity of upper gastrointestinal injury in acute corrosive ingestion: a cross-sectional analytical study.
  3. Comparison of clinical and endoscopic findings between acid and alkali ingestion: a hospital-based comparative cross-sectional study.
  4. Association of oral and oropharyngeal lesions with endoscopic severity of gastrointestinal injury following corrosive ingestion: a cross-sectional analytical study.
  5. Association of dysphagia and odynophagia at presentation with endoscopic severity of injury in acute corrosive ingestion: a hospital-based cross-sectional study.
  6. Association of haematemesis with severity of upper gastrointestinal injury among patients with acute corrosive ingestion: a cross-sectional observational study.
  7. Association of leukocytosis with endoscopic severity of gastrointestinal injury following acute corrosive ingestion: a hospital-based cross-sectional study.
  8. Association of neutrophil-to-lymphocyte ratio with endoscopic severity in acute corrosive ingestion: a cross-sectional analytical study.
  9. Association of serum lactate levels with clinical and endoscopic severity in acute corrosive ingestion: a hospital-based cross-sectional study.
  10. Acid-base and electrolyte abnormalities and their association with clinical severity among patients with acute corrosive ingestion: a cross-sectional observational study.
  11. Comparison of clinical and biochemical characteristics between intentional and accidental corrosive ingestion: a comparative cross-sectional study.
  12. Comparison of patterns and severity of corrosive ingestion between household and industrial corrosive agents: a hospital-based comparative study.
  13. Clinical profile and severity indicators among patients presenting with acute acid ingestion: a cross-sectional observational study.
  14. Association between type of acid ingested and severity of gastrointestinal manifestations at presentation: a hospital-based cross-sectional study.
  15. Clinical and endoscopic characteristics of hydrochloric acid ingestion among adults presenting to a tertiary care hospital: a cross-sectional observational study.
  16. Clinical and endoscopic characteristics of toilet-cleaning acid poisoning presenting to a tertiary care hospital: a hospital-based cross-sectional study.
  17. Comparison of endoscopic severity between toilet-cleaning acid ingestion and other corrosive acid ingestion: a comparative cross-sectional study.
  18. Clinical profile and severity indicators among patients presenting with acute alkali ingestion: a hospital-based observational study.
  19. Comparison of upper gastrointestinal manifestations between acid and alkali poisoning: a cross-sectional comparative study.
  20. Pattern of household corrosive products implicated in acute poisoning and their relationship with severity at presentation: a hospital-based cross-sectional study.
  21. Clinical profile of acute hydrocarbon poisoning presenting to a tertiary care emergency department: a cross-sectional observational study.
  22. Respiratory manifestations and their association with clinical severity in acute hydrocarbon poisoning: a hospital-based cross-sectional study.
  23. Radiological abnormalities and their association with respiratory manifestations in acute hydrocarbon poisoning: a cross-sectional analytical study.
  24. Association of oxygen saturation at presentation with radiological pulmonary abnormalities in acute hydrocarbon poisoning: a hospital-based cross-sectional study.
  25. Neurological manifestations and their association with severity of acute hydrocarbon poisoning: a cross-sectional observational study.
  26. Electrocardiographic abnormalities among patients presenting with acute hydrocarbon poisoning: a hospital-based cross-sectional study.
  27. Acid-base abnormalities and their association with clinical severity in acute hydrocarbon poisoning: a cross-sectional analytical study.
  28. Comparison of clinical manifestations between aliphatic and aromatic hydrocarbon poisoning: a hospital-based comparative cross-sectional study.
  29. Comparison of respiratory manifestations between hydrocarbon poisoning with and without witnessed aspiration: a comparative cross-sectional study.
  30. Clinical and radiological profile of acute kerosene poisoning presenting to a tertiary care hospital: a cross-sectional observational study.
  31. Association of respiratory symptoms with chest radiographic abnormalities in acute kerosene poisoning: a hospital-based cross-sectional study.
  32. Comparison of clinical characteristics of accidental and intentional kerosene poisoning: a cross-sectional comparative study.
  33. Clinical and biochemical profile of acute phenol poisoning presenting to a tertiary care hospital: a cross-sectional observational study.
  34. Association of cutaneous and mucosal manifestations with systemic toxicity in acute phenol poisoning: a hospital-based cross-sectional study.
  35. Renal and hepatic biochemical abnormalities among patients with acute phenol poisoning: a cross-sectional observational study.
  36. Electrocardiographic abnormalities and their association with clinical severity in acute phenol poisoning: a hospital-based cross-sectional study.
  37. Acid-base abnormalities and their association with clinical manifestations in acute phenol poisoning: a cross-sectional analytical study.
  38. Comparison of clinical manifestations between phenol poisoning and other household corrosive poisonings: a hospital-based comparative study.
  39. Pattern and clinical profile of household cleaning-agent poisoning among patients presenting to a tertiary care hospital: a cross-sectional observational study.
  40. Comparison of clinical manifestations between acidic and alkaline household cleaning-agent poisoning: a comparative cross-sectional study.
  41. Respiratory and gastrointestinal manifestations among patients with household cleaning-agent poisoning: a hospital-based cross-sectional study.
  42. Clinical profile of sodium hypochlorite-containing household cleaner poisoning: a cross-sectional observational study.
  43. Comparison of clinical severity between single cleaning-agent exposure and exposure involving mixtures of household cleaning products: a hospital-based comparative cross-sectional study.
  44. Pattern of accidental household chemical poisoning and associated household storage practices: a cross-sectional observational study.
  45. Association between unsafe storage of household chemicals and accidental poisoning among patients presenting to an emergency department: a cross-sectional analytical study.
  46. Knowledge and practices regarding safe storage and handling of household cleaning chemicals among adults attending a tertiary care hospital: a cross-sectional study.
  47. Clinical profile of acute organic solvent poisoning presenting to a tertiary care emergency department: a cross-sectional observational study.
  48. Neurological manifestations and their association with severity of acute solvent poisoning: a hospital-based cross-sectional study.
  49. Hepatic and renal biochemical abnormalities among patients with acute organic solvent exposure: a cross-sectional observational study.
  50. Electrocardiographic abnormalities and their association with clinical manifestations in acute solvent poisoning: a hospital-based cross-sectional study.
  51. Comparison of clinical manifestations between occupational and non-occupational acute solvent exposure: a comparative cross-sectional study.
  52. Association of duration and intensity of occupational solvent exposure with neurological symptoms among industrial workers: an analytical cross-sectional study.
  53. Comparison of neurobehavioural symptoms between solvent-exposed industrial workers and workers without occupational solvent exposure: a comparative cross-sectional study.
  54. Comparison of liver and renal function parameters between solvent-exposed workers and non-exposed controls: a cross-sectional comparative study.
  55. Respiratory symptoms and pulmonary function abnormalities among workers occupationally exposed to organic solvents: a cross-sectional observational study.
  56. Clinical and biochemical profile of acute carbon monoxide poisoning presenting to a tertiary care hospital: a cross-sectional observational study.
  57. Association of carboxyhaemoglobin levels with neurological manifestations in acute carbon monoxide poisoning: a cross-sectional analytical study.
  58. Association of carboxyhaemoglobin levels with level of consciousness at presentation in acute carbon monoxide poisoning: a hospital-based cross-sectional study.
  59. Electrocardiographic abnormalities and their association with severity of acute carbon monoxide poisoning: a cross-sectional observational study.
  60. Association of serum lactate with neurological severity in acute carbon monoxide poisoning: a hospital-based analytical cross-sectional study.
  61. Acid-base abnormalities and their relationship with severity of acute carbon monoxide poisoning: a cross-sectional study.
  62. Comparison of clinical manifestations between patients with carbon monoxide poisoning with and without loss of consciousness: a comparative cross-sectional study.
  63. Comparison of clinical and biochemical findings between accidental and intentional carbon monoxide poisoning: a hospital-based comparative study.
  64. Association between source of carbon monoxide exposure and severity of clinical manifestations: a cross-sectional analytical study.
  65. Clinical characteristics of carbon monoxide exposure among individuals involved in the same household exposure event: a cross-sectional observational study.
  66. Clinical and biochemical profile of acute cyanide poisoning presenting to a tertiary care hospital: a cross-sectional observational study.
  67. Association of serum lactate with clinical severity in suspected acute cyanide poisoning: a hospital-based cross-sectional study.
  68. Acid-base abnormalities and their association with neurological and cardiovascular manifestations in suspected cyanide poisoning: a cross-sectional analytical study.
  69. Comparison of clinical manifestations between suspected cyanide poisoning and other acute industrial toxic exposures: a hospital-based comparative cross-sectional study.
  70. Clinical and biochemical profile of acute methanol poisoning presenting to a tertiary care hospital: a cross-sectional observational study.
  71. Association of metabolic acidosis with visual manifestations in acute methanol poisoning: a cross-sectional analytical study.
  72. Association of arterial blood gas parameters with neurological severity in acute methanol poisoning: a hospital-based cross-sectional study.
  73. Visual manifestations and ophthalmological findings among patients with acute methanol poisoning: a cross-sectional observational study.
  74. Association of serum bicarbonate levels with visual and neurological manifestations in acute methanol poisoning: a hospital-based analytical cross-sectional study.
  75. Electrolyte abnormalities and their association with clinical severity in acute methanol poisoning: a cross-sectional study.
  76. Association of anion gap with clinical severity at presentation in patients with acute methanol poisoning: a hospital-based cross-sectional study.
  77. Association of osmolar gap with clinical manifestations in acute methanol poisoning: a cross-sectional analytical study.
  78. Comparison of clinical and biochemical characteristics between methanol poisoning with and without visual impairment: a comparative cross-sectional study.
  79. Comparison of neurological and metabolic abnormalities between methanol and other toxic alcohol poisoning: a hospital-based comparative study.
  80. Clinical profile and laboratory abnormalities among patients with suspected heavy metal poisoning presenting to a tertiary care hospital: a cross-sectional observational study.
  81. Neurological, gastrointestinal, and haematological manifestations among patients with lead toxicity: a hospital-based cross-sectional study.
  82. Association of blood lead levels with haematological abnormalities among adults with occupational lead exposure: an analytical cross-sectional study.
  83. Association of blood lead levels with neurological symptoms among workers occupationally exposed to lead: a cross-sectional analytical study.
  84. Comparison of haematological parameters between lead-exposed industrial workers and non-exposed workers: a comparative cross-sectional study.
  85. Comparison of renal function parameters between workers with occupational lead exposure and non-exposed controls: a cross-sectional comparative study.
  86. Association of duration of occupational lead exposure with blood pressure and renal function parameters among industrial workers: an analytical cross-sectional study.
  87. Clinical and biochemical manifestations among individuals with occupational mercury exposure: a cross-sectional observational study.
  88. Neurological symptoms and their association with biomarkers of exposure among workers occupationally exposed to mercury: a cross-sectional analytical study.
  89. Clinical and biochemical profile of arsenic toxicity among individuals with documented environmental or occupational exposure: a cross-sectional observational study.
  90. Comparison of haematological, hepatic, and renal parameters between workers occupationally exposed to heavy metals and non-exposed workers: a comparative cross-sectional study.
  91. Pattern of acute industrial poisoning among patients presenting to a tertiary care emergency department in an industrial region of India: a cross-sectional observational study.
  92. Demographic and clinical profile of occupational toxic exposures presenting to a tertiary care hospital: a hospital-based cross-sectional study.
  93. Comparison of clinical manifestations between occupational and non-occupational chemical poisoning presenting to an emergency department: a comparative cross-sectional study.
  94. Pattern of toxic agents, routes of exposure, and use of personal protective equipment among workers presenting with occupational poisoning: a cross-sectional observational study.
  95. Association between use of personal protective equipment and acute toxic exposure-related symptoms among industrial workers: an analytical cross-sectional study.
  96. Knowledge, attitudes, and practices regarding prevention and first aid of occupational chemical poisoning among industrial workers: a cross-sectional study.
  97. Association of workplace safety practices with self-reported acute toxic exposure symptoms among workers in small-scale industries: an analytical cross-sectional study.
  98. Comparison of knowledge and safety practices regarding hazardous chemicals between formally trained and untrained industrial workers: a comparative cross-sectional study.
  99. Pattern of household and industrial chemical poisoning and factors associated with severe clinical presentation among adults attending a tertiary care emergency department: a cross-sectional analytical study.
  100. Comparative clinical and biochemical profile of corrosives, hydrocarbons, household cleaning agents, solvents, toxic alcohols, and industrial chemical poisonings presenting to a tertiary care hospital in India: a hospital-based comparative cross-sectional study.

Forensic Toxicology: Alcohol and Psychoactive Substance Poisoning Thesis Topics

Poisoning presentations, withdrawal syndromes, dependence severity, toxicological screening, and diagnostic agreement studies in emergency and forensic medicine settings. MD/MS Forensic Medicine and Toxicology dissertation titles aligned to NMC curriculum requirements.

  1. Clinical and biochemical profile of acute ethanol intoxication among adults presenting to a tertiary care emergency department in India: a cross-sectional observational study.
  2. Association of blood ethanol concentration with level of consciousness among patients with acute ethanol intoxication: a cross-sectional analytical study.
  3. Association between blood ethanol concentration and Glasgow Coma Scale score in acute ethanol intoxication: a hospital-based cross-sectional study.
  4. Electrolyte abnormalities and their association with clinical severity among patients with acute ethanol intoxication: a cross-sectional observational study.
  5. Acid-base disturbances and their association with level of consciousness in acute ethanol intoxication: a hospital-based cross-sectional study.
  6. Association of admission blood glucose abnormalities with clinical severity in acute ethanol intoxication: a cross-sectional analytical study.
  7. Electrocardiographic abnormalities among patients presenting with acute ethanol intoxication: a hospital-based cross-sectional observational study.
  8. Association of corrected QT interval with blood ethanol concentration and clinical severity in acute ethanol intoxication: a cross-sectional analytical study.
  9. Hepatic biochemical abnormalities among patients presenting with acute ethanol intoxication: a hospital-based cross-sectional study.
  10. Haematological abnormalities and their association with patterns of alcohol consumption among patients presenting with acute ethanol intoxication: a cross-sectional observational study.
  11. Comparison of clinical and biochemical characteristics between isolated ethanol intoxication and ethanol intoxication with co-ingested agents: a comparative cross-sectional study.
  12. Comparison of clinical manifestations between patients with acute ethanol intoxication with and without chronic hazardous alcohol consumption: a hospital-based comparative study.
  13. Clinical profile and biochemical abnormalities among patients presenting with alcohol withdrawal syndrome: a cross-sectional observational study.
  14. Association of electrolyte abnormalities with severity of alcohol withdrawal manifestations at presentation: a hospital-based cross-sectional study.
  15. Association of serum magnesium levels with clinical severity among patients presenting with alcohol withdrawal syndrome: a cross-sectional analytical study.
  16. Electrocardiographic abnormalities and their association with severity of alcohol withdrawal syndrome: a hospital-based cross-sectional study.
  17. Association of liver function abnormalities with severity of alcohol withdrawal manifestations: a cross-sectional observational study.
  18. Comparison of clinical and biochemical characteristics of patients presenting with uncomplicated and complicated alcohol withdrawal: a comparative cross-sectional study.
  19. Prevalence and pattern of hazardous alcohol consumption among adults presenting to a tertiary care emergency department: a cross-sectional study.
  20. Association of hazardous alcohol consumption with haematological and hepatic biochemical abnormalities among adult emergency department attendees: an analytical cross-sectional study.
  21. Clinical and biochemical profile of acute methanol poisoning among adults presenting to a tertiary care hospital: a cross-sectional observational study.
  22. Association of arterial blood gas parameters with neurological severity in acute methanol poisoning: a hospital-based cross-sectional study.
  23. Association of metabolic acidosis with visual manifestations among patients with acute methanol poisoning: a cross-sectional analytical study.
  24. Association between serum bicarbonate concentration and clinical severity at presentation in acute methanol poisoning: a hospital-based cross-sectional study.
  25. Association of anion gap with neurological and visual manifestations in acute methanol poisoning: a cross-sectional analytical study.
  26. Association of osmolar gap with clinical severity among patients presenting with acute methanol poisoning: a hospital-based cross-sectional study.
  27. Ophthalmological manifestations and their association with biochemical abnormalities in acute methanol poisoning: a cross-sectional observational study.
  28. Comparison of clinical and biochemical characteristics between methanol-poisoned patients with and without visual impairment: a comparative cross-sectional study.
  29. Comparison of neurological manifestations between patients with mild and severe metabolic acidosis in acute methanol poisoning: a hospital-based comparative study.
  30. Clinical and biochemical profile of suspected toxic alcohol ingestion presenting to a tertiary care emergency department: a cross-sectional observational study.
  31. Clinical profile of acute opioid poisoning among adults presenting to a tertiary care emergency department: a cross-sectional observational study.
  32. Association of pupillary findings with level of consciousness in acute opioid poisoning: a hospital-based cross-sectional study.
  33. Association of Glasgow Coma Scale score with respiratory depression among patients with acute opioid poisoning: a cross-sectional analytical study.
  34. Arterial blood gas abnormalities and their association with clinical severity in acute opioid poisoning: a hospital-based cross-sectional study.
  35. Electrocardiographic abnormalities among patients with acute opioid poisoning and their association with clinical severity: a cross-sectional observational study.
  36. Association of oxygen saturation with neurological severity among patients presenting with opioid poisoning: a hospital-based cross-sectional study.
  37. Comparison of clinical manifestations between isolated opioid poisoning and opioid poisoning with other psychoactive agents: a comparative cross-sectional study.
  38. Comparison of clinical and respiratory manifestations among patients with different categories of opioid exposure: a hospital-based comparative cross-sectional study.
  39. Clinical and biochemical characteristics of patients presenting with opioid withdrawal syndrome: a cross-sectional observational study.
  40. Association of opioid dependence severity with clinical manifestations of withdrawal at presentation: a cross-sectional analytical study.
  41. Electrocardiographic abnormalities among patients with opioid dependence presenting for treatment: a hospital-based cross-sectional study.
  42. Prevalence and pattern of multiple substance involvement among patients with opioid dependence: a cross-sectional observational study.
  43. Association of multiple substance involvement with severity of opioid dependence among treatment-seeking adults: an analytical cross-sectional study.
  44. Comparison of clinical characteristics between individuals with pharmaceutical opioid dependence and those with non-pharmaceutical opioid dependence: a comparative cross-sectional study.
  45. Pattern of high-risk practices associated with substance use among individuals with opioid dependence attending a tertiary care hospital: a cross-sectional observational study.
  46. Clinical manifestations of acute cannabinoid intoxication among patients presenting to a tertiary care emergency department: a cross-sectional observational study.
  47. Neuropsychiatric manifestations and their association with pattern of exposure among patients with acute cannabinoid intoxication: a cross-sectional analytical study.
  48. Cardiovascular manifestations and electrocardiographic abnormalities among patients with acute cannabinoid intoxication: a hospital-based cross-sectional study.
  49. Comparison of clinical manifestations between isolated cannabinoid intoxication and cannabinoid intoxication with co-ingested agents: a comparative cross-sectional study.
  50. Association between frequency of cannabis exposure and cognitive performance among treatment-seeking adults: a cross-sectional analytical study.
  51. Prevalence of cannabis dependence and associated exposure patterns among patients attending a substance use disorder treatment service: a cross-sectional observational study.
  52. Comparison of neurocognitive performance between individuals with cannabis dependence and non-exposed controls: a comparative cross-sectional study.
  53. Association of duration and frequency of cannabis exposure with psychiatric symptoms among individuals with cannabis dependence: an analytical cross-sectional study.
  54. Pattern of multiple substance involvement among individuals with cannabis dependence attending a tertiary care treatment service: a cross-sectional study.
  55. Comparison of clinical and behavioural characteristics between individuals with isolated cannabis dependence and those with multiple substance involvement: a comparative cross-sectional study.
  56. Clinical and cardiovascular profile of acute sympathomimetic stimulant intoxication presenting to a tertiary care emergency department: a cross-sectional observational study.
  57. Association of heart rate and blood pressure abnormalities with clinical severity in acute sympathomimetic stimulant intoxication: a cross-sectional analytical study.
  58. Electrocardiographic abnormalities and their association with clinical manifestations among patients with acute sympathomimetic stimulant intoxication: a hospital-based cross-sectional study.
  59. Neuropsychiatric manifestations among patients presenting with acute sympathomimetic stimulant intoxication: a cross-sectional observational study.
  60. Comparison of clinical manifestations between isolated stimulant intoxication and stimulant intoxication with other agents: a comparative cross-sectional study.
  61. Pattern of stimulant exposure and associated high-risk practices among treatment-seeking individuals with stimulant use disorder: a cross-sectional observational study.
  62. Association of stimulant exposure pattern with cardiovascular symptoms among individuals attending a substance use disorder treatment service: an analytical cross-sectional study.
  63. Comparison of cardiovascular parameters between individuals with chronic stimulant exposure and non-exposed controls: a comparative cross-sectional study.
  64. Clinical profile of acute sedative-hypnotic poisoning among adults presenting to a tertiary care emergency department: a cross-sectional observational study.
  65. Association of Glasgow Coma Scale score with respiratory abnormalities in acute sedative-hypnotic poisoning: a cross-sectional analytical study.
  66. Electrocardiographic abnormalities among patients with acute sedative-hypnotic poisoning: a hospital-based cross-sectional study.
  67. Comparison of clinical manifestations between benzodiazepine and non-benzodiazepine sedative-hypnotic poisoning: a comparative cross-sectional study.
  68. Comparison of clinical severity between isolated sedative-hypnotic poisoning and poisoning involving ethanol co-ingestion: a hospital-based comparative study.
  69. Clinical characteristics of sedative-hypnotic dependence among patients attending a substance use disorder treatment service: a cross-sectional observational study.
  70. Association of duration of sedative-hypnotic exposure with severity of dependence among treatment-seeking adults: a cross-sectional analytical study.
  71. Pattern and clinical manifestations of novel psychoactive substance exposure among patients attending a tertiary care treatment service: a cross-sectional observational study.
  72. Sociodemographic and exposure profile of individuals reporting contact with novel psychoactive substances: a hospital-based cross-sectional study.
  73. Acute neuropsychiatric manifestations associated with novel psychoactive substance exposure among patients presenting to an emergency department: a cross-sectional observational study.
  74. Cardiovascular manifestations associated with novel psychoactive substance intoxication: a hospital-based cross-sectional study.
  75. Comparison of clinical manifestations between novel psychoactive substance intoxication and established psychoactive substance intoxication: a comparative cross-sectional study.
  76. Pattern of novel psychoactive substance exposure and associated multiple substance involvement among young adults attending a tertiary care treatment service: a cross-sectional observational study.
  77. Awareness and risk perception regarding novel psychoactive substances among college students: a cross-sectional study.
  78. Association between perceived risk and self-reported exposure to novel psychoactive substances among young adults: an analytical cross-sectional study.
  79. Pattern of substance dependence and associated sociodemographic factors among patients attending a tertiary care treatment service: a cross-sectional observational study.
  80. Prevalence and pattern of dependence involving multiple substances among patients attending a tertiary care treatment service: a hospital-based cross-sectional study.
  81. Comparison of dependence severity between individuals with single-substance involvement and multiple substance involvement: a comparative cross-sectional study.
  82. Association of age at first exposure with severity of dependence among treatment-seeking adults: an analytical cross-sectional study.
  83. Association of duration of exposure with severity of dependence among patients attending a tertiary care treatment service: a cross-sectional analytical study.
  84. Comparison of sociodemographic and clinical characteristics between early-onset and late-onset exposure among treatment-seeking adults: a comparative cross-sectional study.
  85. Association of route of administration with dependence severity and high-risk practices among individuals with substance use disorders: an analytical cross-sectional study.
  86. Pattern of medical comorbidities among individuals with substance dependence attending a tertiary care hospital: a cross-sectional observational study.
  87. Pattern of psychiatric symptoms and their association with severity of substance dependence among treatment-seeking adults: a cross-sectional analytical study.
  88. Comparison of clinical and behavioural characteristics between individuals with alcohol dependence and opioid dependence: a comparative cross-sectional study.
  89. Comparison of patterns of multiple substance involvement among individuals with alcohol, opioid, cannabis, and sedative-hypnotic dependence: a hospital-based comparative cross-sectional study.
  90. Association of substance dependence severity with health-related quality of life among patients attending a tertiary care treatment service: a cross-sectional analytical study.
  91. Pattern of toxicological screening results among patients presenting with suspected acute intoxication to a tertiary care emergency department: a cross-sectional observational study.
  92. Comparison of clinically suspected agents with agents detected on urine toxicological screening among patients with acute intoxication: a diagnostic agreement cross-sectional study.
  93. Agreement between self-reported exposure history and urine toxicological screening among patients presenting with acute intoxication: a cross-sectional analytical study.
  94. Prevalence of unsuspected co-ingestants detected by urine toxicological screening among patients with acute intoxication: a hospital-based cross-sectional study.
  95. Comparison of toxicological screening patterns between patients with single-agent and multiple-agent intoxication: a comparative cross-sectional study.
  96. Association between positive multi-analyte urine toxicological screening and clinical severity among patients with acute intoxication: an analytical cross-sectional study.
  97. Pattern of analytes detected by urine toxicological screening among patients presenting with altered sensorium of suspected toxicological origin: a cross-sectional observational study.
  98. Comparison of clinical toxidrome-based assessment with urine toxicological screening findings in patients with suspected acute intoxication: a cross-sectional diagnostic agreement study.
  99. Spectrum of ethanol and psychoactive substances detected among patients presenting with acute poisoning to a tertiary care emergency department in India: a cross-sectional observational study.
  100. Clinical, biochemical, and toxicological screening profile of acute poisoning involving ethanol and psychoactive substances, and factors associated with severe presentation at a tertiary care hospital in India: an analytical cross-sectional study.

Clinical and Forensic Toxicology Thesis Topics

Poisoning patterns and epidemiology, poisoning severity scores, clinical outcomes, toxicological analysis, biological samples, postmortem toxicology, analytical methods, interpretation of toxicology reports, and medicolegal aspects of poisoning deaths.

  1. Pattern and epidemiological profile of acute poisoning cases presenting to a tertiary care hospital in India: a hospital-based cross-sectional observational study.
  2. Sociodemographic and toxicological profile of acute poisoning among adults presenting to a tertiary care emergency department: a cross-sectional study.
  3. Pattern of poisoning agents and circumstances of exposure among patients presenting with acute poisoning to a tertiary care hospital: a cross-sectional observational study.
  4. Comparison of poisoning patterns between rural and urban populations presenting to a tertiary care hospital: a comparative cross-sectional study.
  5. Comparison of acute poisoning patterns between males and females presenting to a tertiary care emergency department: a hospital-based comparative cross-sectional study.
  6. Comparison of poisoning agents and clinical severity across different adult age groups presenting with acute poisoning: a comparative cross-sectional study.
  7. Pattern of intentional and accidental poisoning and their associated sociodemographic characteristics: a hospital-based cross-sectional observational study.
  8. Comparison of clinical characteristics and poisoning severity between intentional and accidental poisoning: a comparative cross-sectional study.
  9. Pattern of poisoning among agricultural and non-agricultural populations presenting to a tertiary care hospital: a cross-sectional observational study.
  10. Comparison of poisoning patterns between agricultural workers and non-agricultural workers: a hospital-based comparative cross-sectional study.
  11. Pattern of poisoning agents according to occupation among adults presenting with acute poisoning: a cross-sectional analytical study.
  12. Seasonal variation in the pattern of acute poisoning cases presenting to a tertiary care hospital: a record-based cross-sectional study.
  13. Monthly distribution and agent-specific patterns of acute poisoning presenting to a tertiary care emergency department: a retrospective record-based observational study.
  14. Pattern of acute poisoning cases according to route of toxic exposure: a hospital-based cross-sectional study.
  15. Association between route of toxic exposure and clinical severity among patients with acute poisoning: an analytical cross-sectional study.
  16. Pattern of single-agent and multiple-agent poisoning among patients presenting to a tertiary care hospital: a cross-sectional observational study.
  17. Comparison of clinical severity between single-agent and multiple-agent poisoning: a comparative cross-sectional study.
  18. Association between delay in hospital presentation and severity at initial assessment among patients with acute poisoning: a cross-sectional analytical study.
  19. Association of referral status with clinical severity at presentation among patients with acute poisoning: a hospital-based cross-sectional study.
  20. Comparison of poisoning patterns among patients referred from peripheral healthcare facilities and those presenting directly to a tertiary care hospital: a comparative cross-sectional study.
  21. Clinical spectrum and severity distribution of acute poisoning cases presenting to a tertiary care emergency department: a cross-sectional observational study.
  22. Association of Glasgow Coma Scale score at presentation with poisoning severity among patients with acute poisoning: an analytical cross-sectional study.
  23. Association of Poisoning Severity Score with clinical and biochemical abnormalities in acute poisoning: a hospital-based cross-sectional study.
  24. Comparison of Poisoning Severity Score across major categories of acute poisoning: a comparative cross-sectional study.
  25. Association between Poisoning Severity Score and requirement for intensive care at initial disposition in acute poisoning: a cross-sectional analytical study.
  26. Association of Poisoning Severity Score with requirement for mechanical ventilation among patients with acute poisoning: a hospital-based analytical study.
  27. Comparison of Glasgow Coma Scale and Poisoning Severity Score for assessment of severity among patients with acute poisoning: a comparative cross-sectional study.
  28. Association of Acute Physiology and Chronic Health Evaluation II score with severity of acute poisoning at intensive care unit admission: a cross-sectional analytical study.
  29. Comparison of Acute Physiology and Chronic Health Evaluation II score and Poisoning Severity Score among critically ill patients with acute poisoning: a comparative cross-sectional study.
  30. Association of Sequential Organ Failure Assessment score at admission with clinical severity among critically ill poisoning patients: a hospital-based cross-sectional study.
  31. Comparison of Sequential Organ Failure Assessment score and Poisoning Severity Score for severity stratification in acute poisoning: a comparative cross-sectional study.
  32. Association of quick Sequential Organ Failure Assessment score with clinical severity among acute poisoning patients presenting to the emergency department: a cross-sectional analytical study.
  33. Comparison of commonly used clinical severity scores in identifying severe acute poisoning at initial hospital assessment: a cross-sectional comparative study.
  34. Association of admission shock index with poisoning severity among adults presenting with acute poisoning: a cross-sectional analytical study.
  35. Comparison of shock index and Poisoning Severity Score for identification of severe poisoning at emergency department presentation: a comparative cross-sectional study.
  36. Association of modified early warning score with severity of acute poisoning at hospital presentation: a cross-sectional analytical study.
  37. Comparison of modified early warning score and Glasgow Coma Scale for severity assessment in acute poisoning: a comparative cross-sectional study.
  38. Association of National Early Warning Score with poisoning severity at emergency department presentation: a hospital-based cross-sectional study.
  39. Relationship between level of consciousness and poisoning severity across different toxicological agents: a cross-sectional analytical study.
  40. Comparative performance of bedside clinical scoring systems for severity stratification of acute poisoning at presentation: a hospital-based comparative cross-sectional study.
  41. Clinical and biochemical factors associated with severe presentation among patients with acute poisoning: an analytical cross-sectional study.
  42. Association of arterial blood gas abnormalities with poisoning severity at presentation: a hospital-based cross-sectional study.
  43. Association of serum lactate levels with severity of acute poisoning at emergency department presentation: a cross-sectional analytical study.
  44. Association of metabolic acidosis with clinical severity among patients presenting with acute poisoning: a hospital-based cross-sectional study.
  45. Association of serum electrolyte abnormalities with poisoning severity at presentation: a cross-sectional analytical study.
  46. Association of admission blood glucose abnormalities with clinical severity in acute poisoning: a hospital-based cross-sectional study.
  47. Association of neutrophil-to-lymphocyte ratio with severity of acute poisoning: a cross-sectional analytical study.
  48. Association of platelet-to-lymphocyte ratio with clinical severity among patients with acute poisoning: a hospital-based cross-sectional study.
  49. Association of red cell distribution width with severity of acute poisoning at presentation: a cross-sectional analytical study.
  50. Comparison of haematological and biochemical parameters between patients with mild and severe acute poisoning: a comparative cross-sectional study.
  51. Pattern of toxic substances detected in biological samples submitted to a forensic toxicology laboratory in suspected poisoning cases: a laboratory-based cross-sectional observational study.
  52. Distribution of toxicological findings in blood, urine, and gastric contents submitted for analysis in suspected poisoning cases: a cross-sectional laboratory study.
  53. Comparison of toxicological detection patterns between blood and urine samples in suspected poisoning cases: a laboratory-based comparative cross-sectional study.
  54. Comparison of toxicological detection patterns between gastric contents and blood samples in acute poisoning cases: a comparative laboratory-based study.
  55. Agreement between clinical diagnosis and laboratory toxicological findings among patients with suspected acute poisoning: a cross-sectional analytical study.
  56. Comparison of clinically suspected poisoning agents with toxicological analysis results in biological samples: a diagnostic agreement cross-sectional study.
  57. Pattern of discordance between clinical diagnosis and toxicological laboratory findings in suspected poisoning: a cross-sectional observational study.
  58. Prevalence of multiple toxic substances detected in biological samples from suspected poisoning cases: a laboratory-based cross-sectional study.
  59. Pattern of pharmaceutical drugs detected in biological samples submitted for toxicological analysis: a cross-sectional observational study.
  60. Pattern of pesticides detected in biological samples submitted to a forensic toxicology laboratory: a laboratory-based cross-sectional study.
  61. Pattern of alcohols and volatile toxic substances detected in forensic biological samples: a cross-sectional observational study.
  62. Comparison of toxicological findings between intentional and accidental poisoning cases: a laboratory-based comparative cross-sectional study.
  63. Association between type of biological sample and detection of suspected toxic agents in poisoning cases: a cross-sectional analytical study.
  64. Comparison of toxicological detection rates in appropriately preserved and inadequately preserved biological samples: a laboratory-based comparative study.
  65. Association of sample storage conditions with qualitative toxicological detection in archived biological specimens: a cross-sectional laboratory study.
  66. Pattern of preanalytical errors in biological specimens received for toxicological analysis at a forensic laboratory: a cross-sectional observational study.
  67. Frequency and types of specimen labelling, sealing, preservation, and documentation errors in medicolegal toxicology samples: a laboratory-based cross-sectional study.
  68. Association of preanalytical sample quality indicators with inconclusive toxicological reports: an analytical cross-sectional study.
  69. Comparison of toxicological findings across different biological matrices in suspected poisoning cases: a laboratory-based comparative cross-sectional study.
  70. Utility of urine toxicological screening in identifying unsuspected substances among clinically suspected poisoning cases: a diagnostic cross-sectional study.
  71. Comparison of immunoassay-based toxicological screening with confirmatory chromatographic analysis for commonly encountered psychoactive substances: a cross-sectional diagnostic accuracy study.
  72. Diagnostic performance of a rapid urine drug screening panel against confirmatory laboratory testing in suspected substance intoxication: a cross-sectional diagnostic accuracy study.
  73. Comparison of thin-layer chromatography and high-performance liquid chromatography for detection of selected toxic substances in biological samples: a laboratory-based comparative study.
  74. Comparison of spectrophotometric and chromatographic methods for quantitative estimation of selected toxic agents in biological specimens: a laboratory-based comparative cross-sectional study.
  75. Analytical performance of a laboratory method for detection and quantification of a commonly encountered poison in biological samples: a cross-sectional method-validation study.
  76. Comparison of two sample preparation techniques for toxicological analysis of commonly encountered poisons in biological specimens: a laboratory-based comparative study.
  77. Evaluation of extraction efficiency of different sample preparation methods for selected drugs in biological matrices: a comparative analytical study.
  78. Assessment of precision, accuracy, linearity, and detection limits of an analytical method used for toxicological estimation in biological samples: a laboratory-based cross-sectional validation study.
  79. Comparison of qualitative screening and quantitative confirmatory methods for detection of selected pharmaceutical poisons: a laboratory-based comparative study.
  80. Pattern of analytical interferences encountered during routine toxicological analysis of biological specimens: a cross-sectional laboratory study.
  81. Pattern of toxicological findings in postmortem biological samples from suspected poisoning deaths: a retrospective cross-sectional forensic study.
  82. Distribution of poisons detected in postmortem toxicological examinations at a tertiary care forensic medicine centre in India: a record-based cross-sectional study.
  83. Comparison of postmortem toxicological findings between intentional, accidental, and undetermined poisoning deaths: a retrospective comparative study.
  84. Comparison of toxicological findings in postmortem blood and viscera among suspected poisoning deaths: a laboratory-based comparative cross-sectional study.
  85. Pattern of pesticide-related poisoning deaths and corresponding postmortem toxicological findings: a retrospective cross-sectional forensic study.
  86. Pattern of pharmaceutical drug-related poisoning deaths and corresponding toxicological findings: a retrospective cross-sectional forensic study.
  87. Pattern of alcohol and substance-related toxicological findings among medicolegal autopsies: a retrospective cross-sectional study.
  88. Comparison of antemortem clinical diagnosis with postmortem toxicological findings in fatal poisoning cases: a retrospective comparative study.
  89. Agreement between history of suspected poison exposure and postmortem toxicological findings in medicolegal poisoning deaths: a cross-sectional analytical study.
  90. Comparison of cause of death assigned before and after availability of toxicological analysis in suspected poisoning deaths: a retrospective comparative study.
  91. Pattern of negative and inconclusive toxicological reports among suspected poisoning deaths and factors associated with such reports: a retrospective cross-sectional study.
  92. Association of postmortem interval with qualitative toxicological findings in biological specimens from suspected poisoning deaths: a record-based analytical cross-sectional study.
  93. Comparison of toxicological findings across blood, urine, vitreous humour, and visceral samples collected during medicolegal autopsy: a comparative cross-sectional study.
  94. Completeness and quality of toxicological sample collection, preservation, sealing, labelling, and documentation in medicolegal autopsies: a cross-sectional audit study.
  95. Pattern of interpretation errors and limitations documented in toxicology reports of suspected poisoning cases: a retrospective cross-sectional study.
  96. Concordance between toxicological laboratory reports and final medicolegal opinion regarding cause of death in suspected poisoning cases: a cross-sectional analytical study.
  97. Completeness of medicolegal documentation in fatal poisoning cases undergoing autopsy at a tertiary care centre: a retrospective cross-sectional audit study.
  98. Pattern of chain-of-custody documentation deficiencies in biological specimens submitted for forensic toxicological analysis: a cross-sectional audit study.
  99. Comparison of demographic, circumstantial, autopsy, and toxicological characteristics of intentional and accidental poisoning deaths: a retrospective comparative cross-sectional study.
  100. Integrated analysis of poisoning circumstances, autopsy findings, biological sample toxicology, and medicolegal opinion in suspected poisoning deaths at a tertiary care centre in India: a retrospective cross-sectional forensic study.

📌 Updated for 2026–2027 MD/MS Forensic Medicine and Toxicology admissions

The list was reviewed for poisoning case-load feasibility, routinely available severity markers, toxicological sample requirements, occupational exposure methods and medicolegal applicability.

  • Most topics can be completed with clinical examination, routine biochemistry, electrocardiography, arterial blood gas analysis, standard severity scores, hospital records and toxicological tests already available in the institution.
  • Advanced mass spectrometry, comprehensive metabolomics, genomic testing and specialised toxicokinetic modelling are not required for the majority of these projects.
  • Publication potential is strongest where exposure identity, time from exposure to sampling, co-ingestants, treatment before sampling and the distinction between screening and confirmatory toxicology are prespecified.
Generate a protocol from any topic above

Select Generate Protocol → beside any title in the list above and receive a submission-ready document built around that topic, containing all eighteen components:

  • Introduction / Synopsis
  • Research Question
  • Aim of the Study
  • Primary Objective
  • Secondary Objectives
  • Materials and Methods
  • Inclusion Criteria
  • Exclusion Criteria
  • Sample Size Calculation
  • Methodology
  • Statistical Analysis
  • Ethical Considerations
  • Review of Literature
  • References
  • Gantt Chart / Study Timeline
  • Patient Information Sheet
  • Consent Form
  • Data Collection Form

Already have your thesis title?

Generate the full FMT toxicology protocol directly — objectives, methodology, sample size, statistics, timeline, references and annexures.

Generate your protocol

Alongside FMT toxicology protocols and synopses, support is also available for departmental presentations, journal club presentations, ethics committee presentations, and posters and oral presentations for medical conferences — for postgraduate residents, board trainees and research scholars across India and the GCC. Prepared by a practising doctor with long experience in medical publishing and thesis supervision.

Enquire on WhatsApp →

FMT toxicology research outside India

The topics above work as research questions anywhere — what changes is the document the institution expects, and who approves it before data collection begins. The Gulf equivalent of an Indian synopsis is the FMT toxicology research proposal submitted to an institutional review board, and it ordinarily carries three sections an Indian synopsis does not: a Gantt chart, a budget and resources section, and a Declaration of Helsinki statement.

Board and residency programmes — country by country

Saudi Arabia — SCFHS and the Saudi Board. Residency and fellowship training under the Saudi Commission for Health Specialties includes a research project with a set timeline, and the FMT toxicology research proposal is the document prepared at the outset and cleared by the institutional review board before recruitment starts.

United Arab Emirates — DHA, DOH Abu Dhabi and MOHAP. Residents training in Dubai, Abu Dhabi and the northern emirates prepare a FMT toxicology research protocol for their programme and submit it for institutional review board approval before any data are collected.

Qatar — QCHP and Hamad Medical Corporation. A FMT toxicology IRB proposal is reviewed before recruitment, with the ethics section written to the institution's own template rather than a generic one.

Bahrain — NHRA. Trainees turning FMT toxicology research topics into a project need the proposal cleared by their institutional research and ethics committee before fieldwork begins.

Oman — OMSB. Residency programmes under the Oman Medical Specialty Board include a research component, and the FMT toxicology research proposal is the document assessed at the start of it.

Kuwait — KIMS. A FMT toxicology study protocol goes to the institutional committee for approval before the project begins.

Arab Board programmes across the region. The Arab Board carries its own research requirement irrespective of the host country, and the FMT toxicology proposal follows the same structure throughout.

Generate a FMT toxicology research proposal →

Postgraduate degrees — Malaysia, the Gulf and beyond

Malaysia — MMed, the National Medical Research Register and MREC. A FMT toxicology dissertation proposal for a Master of Medicine programme carried out in a Ministry of Health facility must be registered on the NMRR and approved by the Medical Research and Ethics Committee before the study begins, and the guidance asks for submission four to six months ahead of data collection. Every investigator on the study team registers on the NMRR as well, so the methodology, ethics and team sections are written in far more detail than an Indian synopsis requires.

PhD and Master's candidates elsewhere. University programmes generally require a full FMT toxicology research proposal of roughly 6,000 to 10,000 words, with an extended literature review, a theoretical framework and a detailed methodology chapter.

PhD and MMed proposals are written individually by a medical doctor and revised until the supervisor accepts them. They are not produced by the automated protocol generator.

Enquire about a FMT toxicology PhD or MMed proposal →

🔥 Trending research areas in FMT toxicology for 2026–27

  • Early severity stratification: admission lactate, acid-base status, electrocardiographic changes and bedside severity scores are being studied because they are available before definitive toxicological confirmation.
  • Clinical-toxicological agreement: comparison of reported exposure, toxidrome assessment and laboratory detection can quantify how often history or bedside diagnosis disagrees with analytical findings.
  • Multiple-agent and psychoactive substance exposure: co-ingestants and multiple substance involvement are increasingly relevant because they alter toxidromes, severity and interpretation of screening results.
  • Forensic sample quality and postmortem interpretation: biological matrix, preservation, chain of custody and timing are central research areas because analytical detection alone does not establish toxicological causation.

Protocol and synopsis guidance

What an FMT toxicology protocol must contain

Fix the time anchor for every clinical and biochemical variable. Glasgow Coma Scale, Poisoning Severity Score, lactate, arterial blood gas values, electrolytes, electrocardiographic changes and organ-function tests can change rapidly after exposure, resuscitation or antidotal treatment. The protocol should state whether measurements are taken at first presentation, before antidote, after referral or at another prespecified time point.

Define how the toxic agent is established. Patient history, container label, toxidrome, screening test and confirmatory toxicological analysis are not equivalent sources of evidence. The protocol should specify the hierarchy used to classify the implicated poison and how uncertain agents, mixed exposures and negative toxicology are handled.

Match the specimen and analytical method to the research question. Blood, urine, gastric contents, vitreous humour and visceral samples have different detection windows and interpretive value. For forensic studies, collection, preservation, sealing, chain of custody and postmortem interval should be recorded because a laboratory result without specimen context can be misleading.

FMT toxicology synopsis versus FMT toxicology protocol

A synopsis presents the research question, rationale, objectives and broad methodology for academic approval, whereas the protocol is the operational document used during recruitment, sampling and analysis. In toxicology, the protocol should specify the exposure definition, timing of presentation, prior treatment, severity scale, co-ingestants, biological matrix, analytical method and the rule used to classify confirmed, suspected and inconclusive poisoning.

The distinction matters because toxicological variables are time-dependent. A synopsis may state that serum lactate will be correlated with severity, but the protocol must define when lactate is measured, whether treatment has already started, which severity assessment is used and whether both measurements refer to the same clinical time point.

Sample size and statistical analysis

Base sample size on the primary toxicological endpoint. Comparative studies require an expected difference in the selected marker or severity category, correlation studies require an anticipated correlation coefficient, and diagnostic-agreement studies require assumptions about agreement, sensitivity or specificity. Rare poisonings may require a longer recruitment or retrospective period rather than an arbitrary large target.

Do not treat repeated measurements as independent patients. Several blood tests, electrocardiograms or toxicological samples from the same patient are correlated observations. If serial measurements are studied, the analysis should account for within-patient change rather than counting each sample as a separate participant.

Separate association from causal or diagnostic interpretation. A biomarker can correlate with poisoning severity without independently predicting it, and a positive screening test can agree with exposure history without confirming causation. Multivariable analysis should consider age, dose, delay to presentation, co-ingestants, prior treatment and major comorbidities when these influence both the exposure marker and clinical severity.

Frequently Asked Questions – Toxicology Thesis Topics (2026–27)

1. How do I choose a feasible FMT toxicology thesis topic in 2026?

Choose a question that matches the poisoning case mix and investigations routinely available in the institution. Organophosphate poisoning, pharmaceutical overdose, corrosive ingestion, toxic alcohol exposure, substance-related presentations and record-based toxicology studies are usually practical when case numbers are adequate. A strong topic has one primary toxicological question, a defined time point for measurement and a realistic plan for identifying the implicated agent.

2. Which study designs are accepted for FMT toxicology research?

Hospital-based cross-sectional, comparative cross-sectional, analytical, retrospective record-based, community-based occupational, diagnostic agreement and forensic laboratory studies are all suitable when matched to the objective. Studies of severity at presentation are usually cross-sectional, whereas toxicological agreement studies compare clinical or exposure history with laboratory findings and should be analysed as agreement or diagnostic studies.

3. What should I settle with my guide before starting the study?

Agree on the poisoning definition, implicated agent or agent group, time anchor for clinical and biochemical measurements, severity scale, handling of co-ingestants, specimen type, toxicological testing method and the outcome used for analysis. For occupational exposure studies, exposure duration, intensity and protective practices should also be defined before recruitment.

4. Can retrospective records be used for an FMT toxicology thesis?

Yes, particularly for poisoning epidemiology, toxicological reports, postmortem toxicology and medicolegal audits. Feasibility depends on whether agent identity, time of exposure, presentation time, co-ingestants, treatment before referral, specimen type and final toxicological findings were recorded consistently. A preliminary review of record completeness is useful before choosing a retrospective topic that depends on these variables.

5. What is the difference between an FMT toxicology synopsis and an FMT toxicology protocol?

The synopsis presents the research question, rationale, objectives and broad methodology for academic approval. The protocol specifies the operational details needed to reproduce the study, including the poisoning case definition, sampling time, clinical severity scale, specimen matrix, analytical method, co-ingestant rules, handling of negative or inconclusive toxicology and the statistical plan.

6. What ethical issues should I address in FMT toxicology studies?

Prospective poisoning studies involving children require guardian consent and child assent from about seven years where appropriate. Record-based and postmortem toxicology studies may seek waiver of consent when permitted by the ethics committee and when confidentiality and medicolegal restrictions are protected. Additional radiation or contrast should not be introduced solely for research, and research-only venepuncture should be avoided unless specifically justified; where extra blood is required, the volume should be explicitly limited according to age and institutional policy. Separate consent is required for identifiable photographs or video. Clinically important incidental findings such as severe metabolic acidosis, dangerous arrhythmia, critical electrolyte disturbance, unexpected co-ingestants or a toxicological result requiring urgent management should have a predefined pathway for communication to the treating or authorised medicolegal team.

7. Why does a positive toxicology result not automatically prove poisoning or cause of death?

A detected substance may represent therapeutic use, previous exposure, contamination, an inactive metabolite or a concentration unrelated to the clinical event. Conversely, a clinically important poison may be missed because the wrong specimen was tested, sampling was delayed, the analytical panel did not include the agent or treatment altered the concentration. Interpretation therefore requires the biological matrix, timing, analytical method, concentration where available, clinical or autopsy findings and exposure circumstances rather than a positive screen alone.

8. How is a PhD proposal different from an MD Forensic Medicine and Toxicology synopsis?

An MD synopsis usually addresses a focused clinical, analytical or medicolegal toxicology question that can be completed during postgraduate training using available patients, records and laboratory facilities. A PhD proposal generally requires broader originality, more extensive analytical validation, advanced toxicological methods, larger or multiple datasets, or several linked objectives. The expected depth, generalisability and duration are therefore different.

9. When should I register my FMT toxicology thesis topic?

Registration should follow confirmation that the required poisoning cases, clinical variables, laboratory assays, toxicological reports and ethics pathway are available. It should occur early enough to standardise sampling and severity assessment before prospective recruitment begins, or to verify the completeness of records before committing to a retrospective design.

Found a topic that fits your department?

Generate its full protocol — objectives, methodology, sample size, statistics, timeline, references and annexures — in editable format.

Generate your protocol